Evolution of the Average Target: Genpact Limited

Evolution of the Target Price: Genpact Limited

Changes in Analyst Recommendations: Genpact Limited

5.QEq-NOcXBYXfT1K6a9wHdY7tK-OCR9gf-13RKuiAwWA.EzjMUqUgS8aQJGv7J7RDObiCbtblM6lvsXChe6vtkQUmAe1OlSB844kqag~10810a32c74e0ee7891087c5410a60ff
08-07 Analyst recommendations: Micron Technology, Lockheed Martin, Airbnb, Johnson Controls International, The Allstate Corporation… Zonebourse
05-11 Mizuho Securities Adjusts Genpact Price Target to $39 From $49, Maintains Neutral Rating MT
12-12 Susquehanna Initiates Genpact With Neutral Rating, $50 Price Target MT
25-08-07 Genpact Q2 revenue, adjusted profit beats estimates RE
25-06-27 TD Cowen Raises Price Target on Genpact to $55 From $53, Maintains Buy Rating MT
25-02-10 Analyst recommendations: Drax, AstraZeneca, HSBC, Broadcom, Tesla... Zonebourse
25-02-10 Analyst recommendations: Aspen, Amazon, Mattel, Broadcom, Tesla… Zonebourse
25-02-07 Deutsche Bank Adjusts Genpact Price Target to $55 From $48, Maintains Hold Rating MT
25-02-07 TD Cowen Upgrades Genpact to Buy From Hold, Adjusts Price Target to $60 From $45 MT
25-01-21 Jefferies Upgrades Genpact to Buy From Hold, Adjusts Price Target to $55 From $44 MT
25-01-21 Analyst recommendations: Apple, On Holding, Amazon, Palo Alto Networks, Tesla... Zonebourse
24-11-11 Deutsche Bank Adjusts Genpact Price Target to $48 From $37, Maintains Hold Rating MT
24-11-11 Analyst recommendations: Moderna, Bristol-Myers Squibb Company, Regeneron Pharmaceuticals, Arista Networks... Zonebourse
24-07-17 JPMorgan Upgrades Genpact to Neutral From Underweight, Price Target is $40 MT
24-07-17 Analyst recommendations: American Airlines, Chevron, UnitedHealth, Bank of America, Eli Lilly... Zonebourse
24-01-30 Mizuho Securities Initiates Genpact With Neutral Rating, Price Target is $40 MT
24-01-17 Citigroup Adjusts Price Target on Genpact to $36 From $35, Maintains Neutral Rating MT
23-12-15 Baird Downgrades Genpact to Neutral From Outperform, Price Target is $38 MT
23-11-13 Wedbush Lowers Genpact's PT to $35 From $45 After Weaker-Than-Expected Q3 Results, Resets Full-Year 2023 Guidance; Keeps Neutral Rating MT
23-08-22 JPMorgan Downgrades Genpact to Underweight From Neutral, Price Target is $40 MT
23-08-11 Needham Adjusts Genpact Price Target to $50 From $56, Maintains Buy Rating MT
23-08-10 Deutsche Bank Adjusts Genpact Price Target to $37 From $48, Maintains Hold Rating MT
23-08-10 BMO Capital Adjusts Price Target on Genpact to $41 From $46, Maintains Market Perform Rating MT
23-07-18 Citigroup Downgrades Genpact to Neutral From Buy, Adjusts Price Target to $42 From $46 MT
23-05-11 JPMorgan Cuts Genpact's Price Target to $46 From $53, Neutral Rating Kept MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+5.96%
+7.91%
+18.47%
+0.89%
+9.53%
+8.11%
+12.39%
+16.88%
+11.36%
Average +10.17%
Weighted average by Cap. +8.02%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
37.53USD
Average target price
42.18USD
Spread / Average Target
+12.39%
High Price Target
58.00USD
Spread / Highest target
+54.54%
Low Price Target
31.00USD
Spread / Lowest Target
-17.40%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AA
  1. Stock Market
  2. Stocks
  3. G Stock
  4. 35G Stock
  5. Consensus Genpact Limited